SMARCB1 and neoplasm: This second group challenges the consequences of a Smarcb1 loss described in literature (e.g., in tumour cells), loss of BAF binding and repression of genes via PRC2 activity [72], and in this way suggest the existence of additional mechanisms by which BAF complexes control gene repression.